Online citations, reference lists, and bibliographies.
← Back to Search

Integrin α5β1 Inhibition By ATN-161 Reduces Neuroinflammation And Is Neuroprotective In Ischemic Stroke

D. Edwards, K. Salmeron, D. Lukins, A. Trout, J. Fraser, G. Bix
Published 2020 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Stroke remains a leading cause of death and disability with limited therapeutic options. Endothelial cell β1 integrin receptors play a direct role in blood-brain barrier (BBB) dysfunction through regulation of tight junction proteins and infiltrating leukocytes, potentially mediated by β1 integrins. Following tandem transient common carotid artery/middle cerebral artery occlusion on wild-type mice, we administered the integrin a5b1 inhibitor, ATN-161, intraperitoneal (IP) injection at 1 mg/kg acutely after reperfusion, on post-stroke day (PSD)1 and PSD2. Systemic changes (heart rate, pulse distension, and body temperature) were determined. Additionally, infarct volume and edema were determined by 2,3-triphenyltetrazolium chloride and magnetic resonance imaging, while neurological changes were evaluated using an 11-point Neuroscore. Brain immunohistochemistry was performed for claudin-5, α5β1, IgG, and CD45 + cells, and quantitative polymerase chain reaction (qPCR) was performed for matrix metalloproteinase-9 (MMP-9), interleukin (IL)-1β, collagen IV, and CXCL12. ATN-161 significantly reduced integrin α5β1 expression in the surrounding peri-infarct region with no systemic changes. Infarct volume, edema, and functional deficit were significantly reduced in ATN-161-treated mice. Furthermore, ATN-161 treatment reduced IgG extravasation into the parenchyma through conserved claudin-5, collagen IV, CXCL12 while reducing MMP-9 transcription. Additionally, IL-1β and CD45 + cells were reduced in the ipsilateral cortex following ATN-161 administration. Collectively, ATN-161 may be a promising novel stroke therapy by reducing post-stroke inflammation and BBB permeability.
This paper references
10.1182/blood.v83.7.1862.bloodjournal8371862
The cell and molecular basis of leukocyte common antigen (CD45)-triggered, lymphocyte function-associated antigen-1-/intercellular adhesion molecule-1-dependent, leukocyte adhesion.
H. Lorenz (1994)
10.1182/BLOOD.V83.7.1862.1862
The cell and molecular basis of leukocyte common antigen (CD45)-triggered, lymphocyte function-associated antigen-1-/intercellular adhesion molecule-1-dependent, leukocyte adhesion.
H. Lorenz (1994)
10.1083/JCB.125.6.1417
Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins
F. Luscinskas (1994)
10.1182/BLOOD.V95.8.2471.007K26A_2471_2480
Oriented endocytic recycling of α5β1 in motile neutrophils
L. Pierini (2000)
10.1083/JCB.153.7.1427
Differential Dynamics of α5 Integrin, Paxillin, and α-Actinin during Formation and Disassembly of Adhesions in Migrating Cells
C. Laukaitis (2001)
10.1002/ijc.10958
Inhibition of integrin α5β1 function with a small peptide (ATN‐161) plus continuous 5‐FU infusion reduces colorectal liver metastases and improves survival in mice
O. Stoeltzing (2003)
10.1083/jcb.200302070
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Takehiro Nitta (2003)
10.1038/sj.bjc.6600710
Expression level of integrin α5 on tumour cells affects the rate of metastasis to the kidney
N. Tani (2003)
10.1021/bi049174+
The synergy peptide PHSRN and the adhesion peptide RGD mediate cell adhesion through a common mechanism.
Y. Feng (2004)
10.1016/j.neuroimage.2006.01.015
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
P. Yushkevich (2006)
10.1038/sj.bjc.6603171
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours
M. Cianfrocca (2006)
10.1158/1535-7163.MCT-06-0100
A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo
P. Khalili (2006)
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCNNH(2)), a beta integrin antagonist, in patients with solid tumours
ME Cianfrocca (2006)
10.1016/j.jneuroim.2006.11.014
The inflammatory response in stroke
Qing Wang (2007)
10.1080/09553000701481808
Integrins: Signaling, disease, and therapy
S. Huveneers (2007)
10.1038/sj.jcbfm.9600378
Stroke-Evoked Angiogenesis Results in a Transient Population of Microvessels
S. Yu (2007)
10.1016/j.nbd.2008.08.005
Blood-brain barrier tight junction permeability and ischemic stroke
Karin E. Sandoval (2008)
10.1158/1078-0432.CCR-07-4530
Pharmacology of the Novel Antiangiogenic Peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-Shaped Dose-Response Curve in Several Preclinical Models of Angiogenesis and Tumor Growth
F. Doñate (2008)
10.1016/j.coph.2007.12.001
Multiphasic roles for matrix metalloproteinases after stroke.
A. Rosell (2008)
10.4161/cam.3.2.8396
Mechanisms and targets for angiogenic therapy after stroke
D. Navaratna (2009)
10.1186/1742-2094-8-186
Interleukin-1α expression precedes IL-1β after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissues
N. Luheshi (2011)
10.1161/STROKEAHA.111.618850
Stroke Treatment Academic Industry Roundtable (STAIR) Recommendations for Maximizing the Use of Intravenous Thrombolytics and Expanding Treatment Options With Intra-arterial and Neuroprotective Therapies
G. Albers (2011)
10.1002/dneu.20954
Extracellular matrix and matrix receptors in blood–brain barrier formation and stroke
K. M. Baeten (2011)
10.1038/jcbfm.2011.99
Interendothelial Claudin-5 Expression Depends on Cerebral Endothelial Cell–Matrix Adhesion by β1-Integrins
T. Osada (2011)
A Interleukin-1alpha expression precedes IL-1beta after ischemic brain injury and is localized to areas of focal neuronal loss and penumbral tissues
NM Luheshi (2011)
10.1016/j.expneurol.2012.06.005
An angiogenic role for the α5β1 integrin in promoting endothelial cell proliferation during cerebral hypoxia
Longxuan Li (2012)
10.1242/bio.20122824
A role for Rap2 in recycling the extended conformation of LFA-1 during T cell migration
P. Stanley (2012)
10.1016/j.pneurobio.2013.11.004
Vascular remodeling after ischemic stroke: Mechanisms and therapeutic potentials
Jialing Liu (2014)
10.1586/14737175.2014.964210
Brain endothelial cell specific integrins and ischemic stroke
Kathleen Guell (2014)
10.1161/ATVBAHA.114.303863
&agr;5&bgr;1 Integrin Signaling Mediates Oxidized Low-Density Lipoprotein–Induced Inflammation and Early Atherosclerosis
Arif Yurdagul (2014)
10.1016/j.clineuro.2014.11.013
Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: From review to preview
S. Grupke (2015)
10.3233/RNN-140491
The temporal expression patterns of fibronectin and its receptors-α5β1 and αvβ3 integrins on blood vessels after cerebral ischemia.
Qijuan Huang (2015)
10.1186/s12929-015-0159-6
Structural basis of blocking integrin activation and deactivation for anti-inflammation
E. J. Park (2015)
The temporal expression patterns of fibronectin and its receptors-alpha5beta1 and alphavbeta3 integrins on blood vessels after cerebral ischemia
Q Huang (2015)
10.1182/blood-2016-03-705160
LFA-1 integrin antibodies inhibit leukocyte α4β1-mediated adhesion by intracellular signaling.
M. Grönholm (2016)
10.1167/iovs.16-19751
Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery.
T. Van Bergen (2016)
Integrin alpha5beta1 inhibition by CLT-28643 reduces postoperative wound healing in a mouse model of glaucoma filtration surgery
T Van Bergen (2016)
LFA-1 integrin antibodies inhibit leukocyte alpha4beta1mediated adhesion by intracellular signaling
M Gronholm (2016)
10.4103/2045-9912.202910
Neuroprotection provided by isoflurane pre-conditioning and post-conditioning
M. Jiang (2017)
10.1177/0271678X16639327
Preconditioning-induced CXCL12 upregulation minimizes leukocyte infiltration after stroke in ischemia-tolerant mice
U. Selvaraj (2017)
10.1016/j.neuroscience.2017.08.040
Vascular expression of angiopoietin1, α5β1 integrin and tight junction proteins is tightly regulated during vascular remodeling in the post-ischemic brain
Jialan Sun (2017)
10.1177/0271678X15616979
Mice deficient in endothelial α5 integrin are profoundly resistant to experimental ischemic stroke
J. Roberts (2015)
10.1371/journal.pone.0184825
Angiopoietin-like protein 2 regulates Porphyromonas gingivalis lipopolysaccharide-induced inflammatory response in human gingival epithelial cells
Tasuku Ohno (2017)
Angiopoietinlike protein 2 regulates Porphyromonas gingivalis lipopolysaccharide-induced inflammatory response in human gingival epithelial cells
T Ohno (2017)
10.1161/CIR.0000000000000558
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
E. Benjamin (2018)
10.1016/j.biomaterials.2018.09.014
Synthetic α5β1 integrin ligand PHSRN is proangiogenic and neuroprotective in cerebral ischemic stroke.
Cheng-Chun Wu (2018)
10.12659/MSM.907446
ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis
Ailing Sui (2018)
10.1155/2018/9168731
Update in the Early Management and Reperfusion Strategies of Patients with Acute Ischemic Stroke
Aldo A Mendez (2018)
10.1056/NEJMoa1713973
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
G. Albers (2018)
Synthetic alpha5beta1 integrin ligand PHSRN is proangiogenic and neuroprotective in cerebral ischemic stroke
CC Wu (2018)
AA Mendez (2018)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar